Abstract:Nesfatin‐1 is an 82‐amino acid anorexigenic peptide which also contributes to the regulation of glucose homeostasis. Mechanisms by which nesfatin‐1 modulates glucose metabolism remain largely unknown. Our studies showed that chronic infusion of nesfatin‐1 by a subcutaneous micro‐pump for two weeks significantly improves the glucose tolerance in both lean and high fat diet induced obese mice, while central administration of nesfatin‐1 demonstrated no effect. Plasma insulin increased significantly after nesfatin‐1 infusion in normal chow diet mice, while no further increment was observed in obese mice. Analysis of insulin signaling revealed that both levels of basal and insulin‐stimulated AKT phosphorylation in the skeletal muscle were markedly increased by nesfatin‐1 relative to the control treatment. Consistent with the alteration of pAKT, the expression and membrane translocation of glucose transporter 4 in the skeletal muscle were significantly increased by nesfatin‐1. In conclusion, nesfatin‐1 may improve glucose metabolism by regulating phosphorylation of AKT in skeletal muscle.

Regulation of Glucose Metabolism by Nesfatin‐1